Home / People / Faculty / Songqing Wang

Songqing Wang——Professor

Room A609, Building 24, Tianjin University
School of Pharmaceutical Science and Technology
Group weblink
Education Experience
1992 Ph. D. Shenyang Pharmaceutical University, CN
Professional Experience
Research Area

The research in the group of Wang involves research and development related to drug advancements and medicinal chemistry, including cardiovascular drugs, anti asthmatic drugs, anti-tumor drugs, anti-virus drugs, anti inflammatory and anti-bacteria drugs, anti-diabetes drugs, benzodiazepine-type hypnotic drugs, non-patented drug development and industrialization.  Synthesis of natural products and their structural modification is carried out in this group.


Honors and Awards
Highlighted Publications
Wang, S.; Zhao, H.-M.; Liu, X.-J. 1-(4-Benzyloxyphenyl)-2-bromopropan-1-one. Acta Cryst. Sect. E. 2007, 63, O151.
Wei, J.; Wang, S.; Gao, S.; Dai, X.; Gao, Q. 3D-pharmacophore Models for Selective A2A and A2B Adenosine receptor Antagonists. J. Chem. Inf. Model. 2007, 47, 613.
Wang, S.; Cao, J.; Liu, X. 2-Benzyl-4-chloro-1-(4-nitro Benzyloxy)benzene. Acta Cryst. Sect. E. 2007, 63, 0683.
Du, Q. S.; Wang, S.; Chou, K. C. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus. Biochem. Biophys. Res. Commun. 2007, 362, 525.
Wang, S.; Fang, L.; Xiu, J.; Liu, J.; Zhao, K. Design, Synthesis, and Hypnotic Activity Studies of Pyrazolo[1,5-a] pyrimidine Derivatives. Chin. Chem. Lett. 2004, 15, 885.
ResearcherID Publications
Year Title Author(s) Source Volume